Literature DB >> 27357316

Prognostic factors for candidaemia in intensive care unit patients: a retrospective analysis.

Yasumasa Kawano1, Atsushi Togawa2, Yoshihiko Nakamura1, Mariko Mizunuma1, Reiko Yamasaki1, Kota Hoshino1, Takeshi Nishida1, Hiroyasu Ishikura1.   

Abstract

INTRODUCTION: Candidaemia, recognised as a fairly common disease among intensive care unit (ICU) patients, carries a poor prognosis. However, as studies on the prognostic factors associated with candidaemia in ICU patients are limited, this study aimed to establish the best prognostic factor for ICU patients with candidaemia in a tertiary care hospital in Japan.
METHODS: We conducted a retrospective cohort study of patients with candidaemia in the emergency ICU at Fukuoka University Hospital, Fukuoka, Japan, from April 2010 to March 2015. Demographic and clinical data was collected from the patients' medical records and laboratory databases.
RESULTS: A total of 25 patients were included in the study. However, 18 patients died during hospitalisation, resulting in an in-hospital mortality rate of 72.0%. The variables of Sequential Organ Failure Assessment (SOFA) score and cumulative number of risk factors for invasive candidiasis showed significant differences between patients in the survivor and non-survivor groups (p < 0.05). The areas under the receiver operating characteristic curves for the SOFA score and cumulative number of risk factors for invasive candidiasis were 0.873 (95% confidence interval [CI] 0.72-1.00) and 0.937 (95% CI 0.84-1.00), respectively.
CONCLUSION: Our results suggest that the cumulative number of risk factors for invasive candidiasis was the most useful prognostic indicator for candidaemia in ICU patients. Copyright: © Singapore Medical Association

Entities:  

Keywords:  candidaemia; intensive care unit; prognostic factor

Mesh:

Year:  2016        PMID: 27357316      PMCID: PMC5392604          DOI: 10.11622/smedj.2016113

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  26 in total

1.  Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.

Authors:  S Koo; L R Baden; F M Marty
Journal:  Clin Microbiol Infect       Date:  2012-03-08       Impact factor: 8.067

2.  Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.

Authors:  Kevin W Garey; Milind Rege; Manjunath P Pai; Dana E Mingo; Katie J Suda; Robin S Turpin; David T Bearden
Journal:  Clin Infect Dis       Date:  2006-05-16       Impact factor: 9.079

Review 3.  International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.

Authors:  J E Edwards; G P Bodey; R A Bowden; T Büchner; B E de Pauw; S G Filler; M A Ghannoum; M Glauser; R Herbrecht; C A Kauffman; S Kohno; P Martino; F Meunier; T Mori; M A Pfaller; J H Rex; T R Rogers; R H Rubin; J Solomkin; C Viscoli; T J Walsh; M White
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

4.  Impact of therapeutic strategies on the prognosis of candidemia in the ICU.

Authors:  Mireia Puig-Asensio; Javier Pemán; Rafael Zaragoza; José Garnacho-Montero; Estrella Martín-Mazuelos; Manuel Cuenca-Estrella; Benito Almirante
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

5.  A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality.

Authors:  Matteo Bassetti; Elda Righi; Filippo Ansaldi; Maria Merelli; Cecilia Trucchi; Trucchi Cecilia; Gennaro De Pascale; Ana Diaz-Martin; Roberto Luzzati; Chiara Rosin; Leonel Lagunes; Enrico Maria Trecarichi; Maurizio Sanguinetti; Brunella Posteraro; Jose Garnacho-Montero; Assunta Sartor; Jordi Rello; Giorgio Della Rocca; Massimo Antonelli; Mario Tumbarello
Journal:  Intensive Care Med       Date:  2014-05-08       Impact factor: 17.440

Review 6.  Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.

Authors:  Cornelius J Clancy; M Hong Nguyen
Journal:  Clin Infect Dis       Date:  2013-01-11       Impact factor: 9.079

Review 7.  Management of invasive candidiasis in critically ill patients.

Authors:  Stijn Blot; Koenraad Vandewoude
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.

Authors:  Cristóbal León; Sergio Ruiz-Santana; Pedro Saavedra; Beatriz Galván; Armando Blanco; Carmen Castro; Carina Balasini; Aránzazu Utande-Vázquez; Francisco J González de Molina; Miguel A Blasco-Navalproto; Maria J López; Pierre Emmanuel Charles; Estrella Martín; María Adela Hernández-Viera
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

9.  Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections.

Authors:  José Garnacho-Montero; Ana Díaz-Martín; Emilio García-Cabrera; Maite Ruiz Pérez de Pipaón; Clara Hernández-Caballero; José A Lepe-Jiménez
Journal:  J Antimicrob Chemother       Date:  2012-09-03       Impact factor: 5.790

10.  Retrospective analysis of epidemiology and prognostic factors for candidemia at a hospital in China, 2000-2009.

Authors:  Xiao-Bing Zhang; Shuang-Jiang Yu; Jun-Xiao Yu; Ya-Li Gong; Wei Feng; Feng-Jun Sun
Journal:  Jpn J Infect Dis       Date:  2012       Impact factor: 1.362

View more
  2 in total

1.  Infectious diseases in Singapore and Asia: persistent challenges in a new era.

Authors:  Lawrence Soon-U Lee
Journal:  Singapore Med J       Date:  2017-04       Impact factor: 1.858

2.  Risk of invasive candidiasis with prolonged duration of ICU stay: a systematic review and meta-analysis.

Authors:  Zhidan Zhang; Ran Zhu; Zhenggang Luan; Xiaochun Ma
Journal:  BMJ Open       Date:  2020-07-12       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.